Date of Award

Spring 1985

Document Type


Degree Name

Master of Science (MS)


Chemistry & Biochemistry



Committee Director

Roy L. Williams

Committee Member

Robert L. Ake

Committee Member

Charles E. Bell

Committee Member

John D. Van Norman

Call Number for Print

Special Collections LD4331.C45J632


Based on an interpretation of the literature of phencyclidine (PCP) together with an examination of the relevant models or prototype structures, this research has attempted to design and synthesize a rigid analog of the phencyclidine structure. The parent ring systems suggested for this study were the 1-arnino and 2-arninornethyltetralins, 10 and, 12.

Several organic compounds, based on this design, have been prepared by classical examples of reductive alkylation reactions of the corresponding 2-hydroxyciethylene-1-tetralones, 11, and by the condensation and subsequent reductive alkylation of the 1-arninotetralin, 9. These arninomethyltetralones, 28, 29 and 30, together with an example of a substituted 1-arninotetralin, 32, have been prepared and properly characterized using classical analytical and spectral techniques. These compounds are illustrated below.

The biological evaluation of these compounds remains incomplete due to the general insolubility of the respective hydrochlorides of arninomethyltetralone. Based on the preliminary data obtained from intraperitoneal injections of three of these compounds, 28, 29., and, 32, as well as intracerebroventricular injections, all in mice, it would appear that these compounds do not possess any PCP agonist or antagonist activity.


In Copyright. URI: This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).